Tag: Rare diseases

London (UCL)

Bringing next-generation gene therapy to the clinic

An interview with Dr Andrea Spezzi, Chief Medical Officer of Orchard Therapeutics Orchard Therapeutics is a biotechnology company funded in November 2015 as part of a partnership with leading research centres, including University College London (UCL) and Great Ormond Street Hospital (GOSH); University California Los Angeles (UCLA) and Boston Children Hospital (BCH), Harvard. Orchard’s missionaaa

Read more
We use cookies to ensure that we give you the best tailored experience on our website based on your preferences. By continuing to use our services, you are giving us your consent to use cookies. Learn more here.